Once-Monthly Maridebart Cafraglutide for Obesity Treatment: UK Guide
Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.